Efficacy and safety of CT-guided microwave ablation for stage I non-small cell lung cancer in elderly patients
MWA is an efficacious tool for patients aged ≥ 75 years with NSCLC. There are no significant differences in efficacy compared with younger patients. Age and CCI are not significant factors associated with prognosis, while IPF/COPD is an independent risk factor.
Authors
- Xiaoguang Li (ORCID: https://orcid.org/0000-0003-4480-3676)
- Jing Luo (ORCID: https://orcid.org/0000-0001-5821-5846)
- Dongdong Wang (ORCID: https://orcid.org/0000-0002-4019-5530)
- Ling Yang
- Zhi‐Xin Bie (ORCID: https://orcid.org/0000-0003-3365-0694)
- Jin-Zhao Peng
- Yuanming Li (ORCID: https://orcid.org/0009-0000-9454-1614)
Institutions
- Qingdao University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Qingdao Municipal Hospital (CN)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1186/s40644-025-00925-6
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chinese Academy of Medical Sciences